(1) Background: The oncology field has drastically changed with the advent of precision
medicine, led by the discovery of druggable genes or immune targets assessed through next …

Despite significant treatment efforts, pancreatic ductal adenocarcinoma (PDAC), the
deadliest solid tumor, is still incurable in the preclinical stages due to multifacet stroma …

Abstract In this study,(z)-5-((3-(2, 3-dihydroxyphenyl) acryloyl) oxy)-1, 3, 4-
trihydroxycyclohexa-2, 4-diene-1-carboxylic acid (chlorogenic acid) was isolated and …

Pancreatic ductal adenocarcinoma is speculated to become the second leading cause of
cancer-related mortality by 2030, a high mortality rate considering the number of cases …

The advent of next-generation sequencing (NGS) has allowed for the identification of novel
therapeutic targets for patients with uncommon cancers. It is well known that fusion …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with
high mortality. Most patients present with an advanced stage of the disease, highlighting the …

Dogs with B-cell lymphoma typically respond well to first-line CHOP-based chemotherapy,
but there is no standard of care for relapsed patients. To help veterinary oncologists select …

Simple Summary The high mortality of pancreatic cancer (PaC) is due to different reasons: a
lack of specific symptoms, an unlikely diagnosis, therapies' paucity, and drug resistance …

Owing to the significant challenges encountered in the diagnosis, management, and
treatment of benign prostatic hyperplasia (BPH), which have emerged as essential clinical …

Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case
Report and Mechanistic Overview | JCO Precision Oncology Skip to main content ASCO …